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Abstract : Vibrio parahaemolyticus is a foodborne bacterium that causes acute gastroenteritis through the con-
sumption of contaminated, raw, or undercooked seafood. Cystic fibrosis transmembrane conductance regulator 
(CFTR) is a well-characterized chloride channel that regulates several other ion channels and transporters to 
maintain water homeostasis in the gut lumen. Also, CFTR is a main target of bacterial infection-associated diar-
rhea. Hence, the aim of this study was to clarify the contribution of CFTR in V. parahaemolyticus-induced diar-
rhea in a mouse model of intestinal loop fluid accumulation, with CFTR inhibitors and a CFTR knockout model. 
The results indicated that CFTR plays a critical role in fluid accumulation in response to V. parahaemolyticus 
infection. We also investigated the inflammatory association in CFTR-mediated V. parahaemolyticus-induced 
fluid secretion with cyclooxygenase inhibitors and found that fluid accumulation was decreased by inhibition 
of cyclooxygenase 2 produced by neutrophils. These findings suggest that V. parahaemolyticus-inducing infil-
tration and activation of neutrophils also participated in CFTR mediated fluid secretion. This study reveals an 
important relationship between V. parahaemolyticus-induced diarrhea and inflammation in a mouse model. J. 
Med. Invest. 68 : 59-70, February, 2021
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INTRODUCTION
 
Vibrio parahaemolyticus is a marine, halophilic, Gram-negative 
bacterium that causes acute gastroenteritis via the consump-
tion of contaminated, raw, or undercooked seafood with clinical 
symptoms manifesting as diarrhea, abdominal cramps, nau-
sea, vomiting, and fever (1). Moreover, biopsies indicate that V. 
parahaemolyticus infection causes a disruption to the intestinal 
epithelium along with inflammation (2), suggesting that the clin-
ical symptoms are largely associated with inflammation. The 
signs of V. parahaemolyticus infection have been observed by the 
intestinal loop test of rabbit ileal and an oral inoculation model 
of infant rabbits (3, 4).
For many years, thermostable direct hemolysin (TDH) and 
TDH-related hemolysin (TRH) have been considered as the 
main pathogenicity factors of V. parahaemolyticus. TDH forms 
pore complexes in the host cell membrane, resulting in hemolysis 
and cytotoxicity (5-8). TDH allows the flow of both water and 
ions across the host membrane, which induces Cl- secretion (9, 
10). TRH is immunologically related to TDH and induces Cl- se-
cretion similar to the TDH (11). In fact, a TDH-deficient mutant 
decreased fluid accumulation but which strain showed partial 
fluid accumulation in a rabbit model (12). On the other hand, 
strains lacking the type 3 secretion system (T3SS) 2, which is 
encoded on chromosome 2 (T3SS2), failed to induce diarrhea 
and infection-associated inflammation in these animal models 
(3, 13). Reportedly, the mechanism of T3SS2 mediated diarrhea 
was revealed in detail that induced by VopV effector, an F-ac-
tin-binding protein, and TDH secreted by T3SS2 system (14, 
15). These data strongly suggest that the TDH and T3SS2 are 
the main virulence factor in V. parahaemolyticus-induced diarrhea 
(3, 4, 16, 17).
In contrast to the T3SS2, T3SS1, a second secretion system 
that is encoded on chromosome 1, is found in all V. parahaemolyt-
icus strains including nonpathogenic isolates (18). The virulence 
of the T3SS1 has been associated with cytotoxicity and cytokine 
production in cultured cell models (3, 5, 19-22). Despite the 
strong virulence observed in in vitro studies, the T3SS1 plays 
only a relatively minor role in pathogenesis within the animal 
gastrointestinal tract (3, 4). Thus, the contribution of the T3SS1 
to the clinical symptoms of  V. parahaemolyticus infection, particu-
larly diarrhea and inflammation, remains unclear.
The mucosal layer of the intestinal tract acts as a defense 
system against infection by preventing attachment and accumu-
lation of pathogenic bacteria. Accordingly, several ion channels 
and transporters closely maintain cellular homeostasis in the 
mucosal layer. During the infection process, several ion channels 
and transporters are excessively activated by virulence factors, 
which lead to failed ion homeostasis and the onset of diarrhea via 
disruption of the balance of electrolyte absorption and secretion 
(23). Severe diarrhea causes loss of body water and electrolytes, 
which lead to dehydration and acidosis. Notably, diarrhea can be 
especially fatal to infants, the elderly, and the disabled.
It is known that infection of pathogenic bacteria, such as Vibrio 
cholerae, enterotoxigenic Escherichia coli (ETEC), and entero-
pathogenic E. coli, causes excessive fluid loss, which leads to se-
cretory diarrhea. The mechanisms of secretory diarrhea caused 
by infection with V. cholerae and ETEC have been described 
in previous reports. Cholera toxin and heat-stable enterotoxin 
produced by ETEC activate the cystic fibrosis transmembrane 
conductance regulator (CFTR), which leads to the production of 
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cyclic adenosine monophosphate (cAMP) and cyclic guanosine 
monophosphate (24, 25). Moreover, overactivation of CFTR caus-
es increased secretion of anions and fluid, which leads to severe 
diarrhea.
Although CFTR plays a key role in secretory diarrhea, its con-
tribution to V. parahaemolyticus-induced severe diarrhea remains 
unclear, as few studies have examined the association between 
CFTR activity and TDH or TRH with a focus on toxin secretion 
(11). Therefore, the aim of the present study was to determine 
the contribution of CFTR in V. parahaemolyticus-induced severe 
diarrhea with the use of living bacteria and an in vivo mouse 
model of intestinal infection. A secondary aim was to assess the 
extent of inflammation associated with CFTR-mediated fluid 
imbalance caused by V. parahaemolyticus infection. The results of 
this study demonstrate that the production of prostaglandin E2 
(PGE2) via cyclooxygenase 2 (COX-2) produced by neutrophils 
activated CFTR and induced diarrhea. These data strongly 
suggest that V. parahaemolyticus-induced inflammation also par-
ticipates in the induction of diarrhea. In addition, the efficacy of 
diarrhea treatment targeting V. parahaemolyticus-induced inflam-
mation was investigated. 
MATERIALS AND METHODS
Bacterial strains and culture conditions
V. parahaemolyticus strain RIMD2210633 (Kanagawa phenom-
enon-positive, serotype O3 : K6) was used as a standard strain. 
The bacteria were cultured at 37℃ with shaking in Luria–Bertani 
medium supplemented with 3% NaCl. Deletion mutant strains 
(DtdhAS, DT3SS1, DT3SS2) were previously described (3, 12, 
26).
Preparation of bacterial suspension
V. parahaemolyticus cells were collected after overnight culture 
by centrifugation and washed two times in phosphate-buffered 
saline (PBS). The optical density of the bacterial suspension was 
adjusted to 1.0 at a wavelength of 600 nm (OD600) with PBS.
Animals 
6-week-old C57BL / 6J male mice (Japan SLC, Tokyo, Japan 
or Charles River Japan, Kanagawa, Japan) were obtained 
from Japan SLC (Tokyo, Japan) and Charles River Japan 
(Kanagawa, Japan). After 1-week adaption, that mice were 
used for infection experiment. The Cftr tm1Unc+/- mouse were origi-
nally obtained from The Jackson Laboratory (Bar Harbor ME, 
USA.), that mouse was bred onto the C57BL / 6J background 
until congenic. Cftr tm1Unc+/- mice were bread to obtain Cftr tm1Unc-/- 
(CFTR -/- : CFTR knockout mice) and Cftr tm1Unc+/+ (CFTR+/+ : WT) 
mice. WT and CFTR knockout mice were fed a liquid diet 
(ENSURE LIQUD : ABBOTT JAPAN, Tokyo) to prevent the 
lethal intestinal obstruction in CFTR knockout mice. 7-week-old 
WT and CFTR knockout male mice were used for loop assay.
Mouse intestinal loop assay
WT C57BL / 6J mice and CFTR knockout mouse were used for 
the mouse intestinal loop assay (27, 28). About creation of loops, 
mice were anesthetized, and small abdominal incision was made 
to expose the intestine. During the surgery, body temperature 
was maintained at 38°C using a heating pad. For the jejunal 
closed-loop model, 2–3-cm loops were created by sutures. V. para-
haemolyticus bacterial suspension (250 μL, OD600 = 1.0) prepared 
in PBS or just PBS alone (250 μL) was injected into the intes-
tinal loops and infection was allowed for 4 h. Loop assay was 
applied one loop in one mouse for each condition. After infection, 
the intestinal loops were removed, and fluid accumulation was 
quantified by determining the loop weight / length ratio. To in-
vestigate the role of CFTR in diarrhea, glybenclamide (final con-
centration, 300 μM ; Sigma-Aldrich Corporation, St. Louis, MO, 
USA), 2-(phenylamino) benzoic acid (DPC ; 500 μM ; Wako Pure 
Chemical Industries, Ltd., Osaka, Japan), and a CFTR inhibitor 
were individually added to the V. parahaemolyticus bacterial sus-
pension (OD600 = 1.0). Furthermore, to examine the relationship 
between COX and diarrhea, indomethacin (5 mg / kg ; Sigma-Aldrich 
Corporation) and NS398 (5 mg / kg ; Sigma-Aldrich Corporation) 
were individually added to the V. parahaemolyticus bacterial sus-
pension (OD600 = 1.0), which was then injected into the intestinal 
loops.
Cell culture
RAW264.7 cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM ; Sigma-Aldrich Corporation) supplemented 
with 10% fetal bovine serum (FBS ; Gibco BRL) and 100 μg / mL 
gentamicin (Sigma-Aldrich Corporation). The cells were seed-
ed on 6-well culture dashers at a density of 1 × 106 cells / well. 
RAW264.7 cells that had been cultured for 4 days were used for 
subsequent experiment.
Isolation of intraperitoneal macrophages
In order to isolate the intraperitoneal macrophages, 7-week-
old C57BL / 6J mice were infected with 2 ml thioglycolate medi-
um intraperitoneally. After 4 days, mice were euthanized, and 
macrophages were collected with ice-cold PBS. The cells were 
centrifuged at 1,000 rpm for 10 min at 4℃ and resuspended 
with RPMI1640 medium (GIBCO BRL). After washing with 
RPMI1640, the cells were resuspended with RPMI1640 medium 
containing with 10% FBS and 100 μg / mL gentamicin and seed-
ed on 24-well culture dashers at a density of 1 × 106 cells / well.
Infection protocol of in vitro experiment
At least, 1 hours before infection, the culture medium of 
RAW264.7 cells and isolated intraperitoneal macrophages were 
replaced with fresh DMEM (without supplements) or RPMI1640 
(without supplements), respectively. After cultivation, bacteria 
were washed and resuspended in PBS. Bacteria were added 
to each well (1 × 107 colony-forming units / dish).Infection were 
allowed to proceed at 37℃ in 5% CO2.
Analysis by capillary electrophoresis-time of flight mass spectrom-
etry (CE-TOFMS)
Briefly, 30 mg of frozen mouse intestinal samples were trans-
ferred into 500 μL of methanol containing an external standard 
(50 μM) and homogenized with zirconia beads using a Multi-
beads shocker®. To remove the phospholipid content, 500 μL 
of chloroform and 200 μL of Milli-Q water were added to the 
homogenate, which was then vortexed for 30 s and centrifuged 
at 2,300 × g for 5 min at 4℃. The aqueous layer was prepared 
by centrifugal ultrafiltration at 9,100 × g and 4℃ to remove 
proteins and completely dried in a vacuum centrifuge. Then, 
the dried samples were dissolved in 25 μL of Milli-Q water to 
prepare the metabolites. The samples were analyzed using a CE-
TOFMS system (Agilent Technologies, Santa Clara, CA, USA).
HE staining
Mouse intestinal loops were washed with PBS and fixed in 
4% paraformaldehyde for 2 days, then embedded in paraffin 
and sliced into 3 μm-thick sections, which were plated on glass 
slides. The slides were stained with HE, mounted in malinol 
(Muto Pure Chemicals, Co., Ltd., Tokyo, Japan), and observed 
under an OLYMPUS BX50 microscope (Olympus Corporation, 
Tokyo, Japan).
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Western blot analysis
Mouse intestinal loops were removed after infection, cut 
open, and washed with PBS. The epithelial tissues of the loops 
were placed in radioimmunoprecipitation assay buffer (500 
μL) and homogenized. After centrifugation, the supernatant 
was collected. Proteins (50 μg) were resolved by 8% sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis and trans-
ferred to polyvinylidene difluoride membranes. The membranes 
were blocked for 60 min in 3% skim milk in Tris-buffered 
saline with Tween 20 (TBST) and washed three times with 
TBST for 10 min. Then, the membranes were incubated over-
night with a primary rabbit anti-COX-1 antibody (Ab) (dilution, 
1 : 1000 ; Cayman Chemical Company, Ann Arbor, MI, USA), 
mouse anti-COX-2 Ab (1 : 1000 ; BD Biosciences, San Jose, 
CA, USA), rabbit anti-myeloperoxidase (MPO) heavy chain Ab 
(1 : 1000 ; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), and 
rabbit anti-β actin Ab (1 : 1000 ; Santa Cruz Biotechnology, Inc.) 
diluted in 3% skim milk in TBST. The membranes were washed 
three times with TBST for 10 min and incubated for 2 h with a 
secondary Ab : anti-rabbit immunoglobulin (Ig)G (1 : 2000 ; Bio-
Source International, Inc., San Diego, CA, USA) or anti-mouse 
IgG (1 : 2000 ; BioSource International, Inc.) diluted in 3% 
skim milk in TBST. After washing, bound Abs were detected 
using enhanced chemiluminescence reagent (Tris, 100 mM ; lu-
minol, 1.25 mM ; p-coumaric acid, 225 μM ; pH 8.5). Bands 
were scanned in a luminescent image analyzer (LAS-3000 UV 
mini ; Fujifilm Global, Tokyo, Japan).
RNA extraction and reverse transcription
Mouse intestinal loops were removed after infection, cut open, 
and washed with PBS. Total RNA from the epithelial tissues of 
the loops was extracted using TRIzol reagent (Thermo Fisher 
Scientific, Waltham, MA, USA). The RNA was treated with 
RNase-free DNase I (Takara Bio, Inc., Shiga, Japan) to elimi-
nate contaminating DNA. Reverse transcription of RNA (1.0 μg) 
was performed using the PrimeScript RT-Reagent Kit (Takara 
Bio, Inc.).
Real-time reverse transcription-polymerase chain reaction. (Re-
al-time RT-PCR)
Real-time RT-PCR was performed using 2 μL of reverse-tran-
scribed product, 0.2 μM of each primer, and 10 μL of SYBR 
Premix Ex Taq polymerase (Takara Bio, Inc.) with a LightCycler 
Real-Time PCR System (Roche, Basel, Switzerland) and specific 
primers listed in Table 1. 18S ribosomal RNA was used as an 
internal standard to normalize mRNA expression levels of COX-
1, COX-2, IL-1β, MIP-2, MCP-1 and TNF-α.
Immunostaining
The loops were embedded in paraffin as described above. After 
deparaffinization, the tissue sections were blocked for 60 min in 
1% bovine serum albumin (BSA) in PBS, then incubated over-
night with a primary Ab (rabbit anti-COX-2, 1 : 250, BD Biosci-
ences) diluted in 1% BSA solution at 4℃. Afterward, the tissues 
were washed with PBS prior to incubation with a secondary Ab 
(Alexa fluor488, 1 : 250, Thermo Fisher Scientific) in 1% BSA 
solution for 60 min in the dark and then washed with PBS again. 
In addition, the slides were incubated overnight with primary Ab 
(rabbit anti-MPO heavy chain, 1 : 500, Santa Cruz Biotechnolo-
gy, Inc.) in 1% BSA solution at 4℃, then washed with PBS and 
incubated with a secondary Ab (Alexa fluor568, 1 : 250, Thermo 
Fisher Scientific) in 1% BSA solution at room temperature for 60 
min. After washing with PBS, the slides were incubated with 4 ,́ 
6-diamidino-2-phenylindole dihydrochloride (143 nM ; Thermo 
Fisher Scientific) in PBS for 5 min at room temperature. Af-
terward, the slides were washed with PBS and mounted with 
Fluorescent Mounting Medium (Dako, Glostrup, Denmark). Flu-
orescent images of the slides were obtained with an OLYMPUS 
BX50 microscope (Olympus Corporation).
Statistical analysis
Statistical analysis was performed using the Student’s t-test 
or one-way analysis of variance (ANOVA) with Tukey kramer’s 
test with Statcel 4. (OMS Publishing, Tokorozawa, Japan). A 
probability (p) value of > 0.05 or 0.01 were considered statistical-
ly significant.
RESULTS
Contribution of CFTR in V. parahaemolyticus-induced fluid accu-
mulation as determined with the mouse intestinal loop test
To evaluate the relationship between CFTR and fluid accu-
mulation in V. parahaemolyticus infection, the mouse intestinal 
loop assay was performed with the use of CFTR inhibitors. The 
results of the mouse intestinal loop assay showed that infection 
with V. parahaemolyticus for 4h increased fluid accumulation 
(AV ± SD : 0.090 ± 0.033) as compared with non-infected loops 
(0.050 ± 0.009) (Fig 1A). Glybenclamide and DPC (a CFTR in-
hibitor) treatment attenuated fluid accumulation in V. parahaemo-
lyticus-infected mouse loops (VP + Glybenclamide ; 0.070 ± 0.019, 
VP + DPC ; 0.049 ± 0.009), to levels similar to that of non-infect-
ed loops (0.050 ± 0.009). We have confirmed that this inhibitor 
does not affect the viability of the bacteria (Fig S1). Next, CFTR 
knockout mice were used to elucidate the contribution of CFTR 
in V. parahaemolyticus-induced fluid accumulation. As shown in 
Fig 1B, V. parahaemolyticus infection failed to induce fluid accu-
mulation in the CFTR knockout mice (0.061 ± 0.019). These data 
indicate that V. parahaemolyticus induced CFTR-mediated fluid 
accumulation in the mouse loop model.
V. parahaemolyticus infection induced elevation of PGE2 and γ-am-
inobutyric acid (GABA)
CE-TOFMS metabolome analysis was performed to elucidate 
the effect of CFTR activation during V. parahaemolyticus infection 
Table 1.　Sequences of the primers used for Real-time RT-PCR.
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Fig 1.　CFTR association with V. parahaemolyticus-induced fluid accumulation. (A) Bacterial suspensions with 
CFTR inhibitors were injected into mouse intestinal loops. After infection for 4 h, the loops were removed and fluid 
accumulation was calculated (n = 5 to 8). Upper horizontal line of box, 75th percentile ; lower horizontal line of box, 25th 
percentile ; horizontal bar within box, median ; upper horizontal bar outside of box, maximum value ; lower horizontal bar 
outside of box, minimum value. Different letters of the alphabet indicate statistical difference (p < 0.05) from each other as 
determined by ANOVA with Tukey Kramer’s test. (B) Bacterial suspension or PBS was injected to the intestinal loops of 
CFTR knockout mouse. After infection for 4 h, the loops were removed and fluid accumulation was calculated (n = 5 to 7). 
Box plot showing fluid accumulation, as determined with a mouse intestinal loop assay. Upper horizontal line of box, 75th 
percentile ; lower horizontal line of box, 25th percentile ; horizontal bar within box, median ; upper horizontal bar outside 
of box, maximum value ; lower horizontal bar outside of box, minimum value. Different letters of the alphabet indicate 
statistical difference (p < 0.05) from each other as determined by ANOVA with Tukey Kramer’s test.
Fig S1.　Effect of each inhibitors on bacterial viability. The bacterial cells were incubated with each inhibitors at 37℃ 
for 6 h. After that, the cells were separated on LB agar plate and incubated at 37℃ for 16 h. The bacterial viability was 
estimated with colony number. Those data indicated that each inhibitor did not affect bacterial viability. The error bar 
indicates standard deviation.
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for 4 h of mouse ileal tissue (Fig S2). Because the infection 
process was relatively short term, there was no significant 
difference between the infected and non-infected samples. How-
ever, there were some differences in CFTR activity-associated 
components. Specifically, V. parahaemolyticus infection increased 
PGE2 production by 1.4-fold (p = 0.045) and GABA production by 
1.8-fold (p = 0.003) in the mouse intestinal loops (Fig S3).
COX-2 inhibitor decreased fluid accumulation in the mouse intestine
Intracellular cAMP production is regulated by PGE2, which 
in turn is regulated by COX catalysis. So, we next investigated 
the contribution of COX-mediated PGE2 production to the ac-
cumulation of fluid in the mouse intestinal loop with the use of 
three different types of COX inhibitors and found that treatment 
with indomethacin (a COX inhibitor) (0.051 ± 0.017) and NS398 
(a selective COX-2 inhibitor) (0.062 ± 0.011) attenuated V. para-
haemolyticus-induced fluid accumulation (Fig 2). Those inhibitors 
did not affect the viability of the bacteria (Fig S1). These data 
strongly suggest that COX-2-mediated PGE2 production partic-
ipates in V. parahaemolyticus-induced fluid accumulation in the 
mouse intestine.
 
COX-2 expression was up-regulated in V. parahaemolyticus
In order to identify the PGE2-producing cells, histological 
changes to V. parahaemolyticus-infected tissue were investigat-
ed (Fig 3A-B). After infection with V. parahaemolyticus, which 
revealed inflammation was confirmed by expression of mRNA 
level in inflammatory cytokine (Fig 3C) and the migration of 
neutrophils via western blot analysis with the use of Abs against 
MPO, an established marker of neutrophils (Fig 3D).
Next, western blot and RT-PCR analyses were performed to 
evaluate COX-2 expression levels in V. parahaemolyticus-infected 
mouse tissue. As shown in Fig 4, COX-1 and COX-2 protein 
expression level were up-regulated in V. parahaemolyticus-infected 
tissues, but COX-2 was more significantly increased. Further, 
the mRNA expression levels of COX-1 and COX-2 were analyzed 
by real-time RT-PCR. Similar to the protein level, COX-2 mRNA 
expression was increased by V. parahaemolyticus infection (Fig 
4C).
COX-2 and MPO were co-localized in mouse intestine following 
infection with V. parahaemolyticus
Next, we investigated the distribution of COX-2 in V. parahae-
molyticus-infected tissues by immunostaining with Abs against 
COX-2 and MPO. As shown in Fig 5, COX-2 was expressed in 
a portion of the neutrophils that had infiltrated the mouse in-
testine. Meanwhile, MPO was highly co-localized with COX-2. 
These data suggest that COX-2-mediated PGE2 production was 




It is known that CFTR is main target of bacterial toxin which 
induces secretary diarrhea. In this study, we found CFTR medi-
ated fluid accumulation in V. parahaemolyticus infection, and its 
channel activation was closely associated with V. parahaemolyticus-
induces inflammation. In order to estimate the contribution of 
each V. parahaemolyticus virulence factor on COX-2 expression in 
leucocyte, we used mouse macrophage cell line RAW264.7 cells 
and peritoneal macrophage cells for in vitro infection model. Each 
virulence factor deletion-mutant (ΔT3SS1, ΔT3SS2, and ΔTDH) 
indicated COX-2 expression. Moreover T3SS1 deletion mutant 
induced high-expression level of COX-2 (Fig S4A). Those data in-
dicated that T3SS1, T3SS2, and TDH were not associated with 
production of COX-2 in leucocyte. On the other hands, even the 
killed V. parahaemolyticus (heat-killed, UVC-killed, gentamycin 
treated V. parahaemolyticus) induced COX-2 expression (Fig S4A-
B). It suggest that, COX-2 expression in macrophage cells were 
easily activated by bacterial endotoxins, such as LPS. However, 
those killed bacteria could not induced fluid accumulation and 
neutrophil migration in mouse loop test (Fig S5). Those results 
suggest that the both migration and activation of neutrophils are 
necessary for fluid accumulation in a mouse intestinal model of 
V. parahaemolyticus infection.
Taken together, our data suggest that V. parahaemolyticus in-
fection induced migration of neutrophils and PGE2 production 
to the site of infection in a mouse infection model. Further-
more, PGE2 production might activate CFTR-mediated fluid 
accumulation. These findings illustrate the importance of the 
inflammatory response in V. parahaemolyticus-induced diarrhea, 
as the production of inflammatory factors was involved in the 
CFTR-mediated fluid accumulation in response to V. parahaemo-
lyticus infection.
There are several pathways involved in the activation of 
CFTR. In addition, several compounds are known to elevate the 
intracellular cAMP content by inhibition of phosphodiesterase (a 
cAMP-degrading enzyme) and activation of adenylyl cyclase (a 
cAMP-synthesizing enzyme) (29). PGE2 is a known activator of 
adenylyl cyclase in the intestinal epithelium, and it causes syn-
thesis of cAMP under the catalytic influence of adenylyl cyclase 
(30). Therefore, we suspect that increasing PGE2 production 
by neutrophils will upregulate intracellular cAMP content in 
intestinal epithelial cells. In addition, cell-to-cell crosstalk may 
activate CFTR-mediated diarrhea. Finally, the roles of cAMP 
and PGE2 in V. parahaemolyticus infection of mouse intestinal 
tissues were investigated using an enzyme-linked immunosor-
bent assay and CE-TOFMS system. Unfortunately, there was no 
definite increase in PGE2 or cAMP production in V. parahaemo-
lyticus-infected mouse intestinal tissues (Fig S3). Thus, the direct 
effect of PGE2 production by neutrophils on CFTR activation in 
epithelial cells during V. parahaemolyticus infection remains un-
clear. However, there is a possibility that the production of cAMP 
or PGE2 was limited and biased toward the mucus layers at the 
site of infection. In this study, cAMP and PGE2 levels were mea-
sured in whole tissues, but the production of the target markers 
may have been downregulated in the base tissue. Therefore, an 
alternative strategy is needed to investigate the exact production 
of PGE2 and cAMP during infection, such as the isolation of the 
mucus layer. Also, we plan to perform future experiments with 
a co-culture system to reveal the direct effect of PGE2 on CFTR 
production by neutrophils on epithelial cells.
A previous study revealed that T3SS1 is closely associated 
with V. parahaemolyticus-induced inflammation. T3SS1 effective-
ly activates inflammation-associated signaling cascades, such 
as the nuclear factor-κβ and mitogen-activated protein kinase 
pathways (ERK1 /2, p38, and JNK) (19, 21, 31). As confirmation 
of the contribution of T3SS1 in V. parahaemolyticus-induced PGE2 
production, we observed a tendency where PGE2 production 
was increased in mouse intestinal tissues in response to V. 
parahaemolyticus production, and the production level was lower 
in a T3SS1-deletion mutant. However, the PGE2 production 
level was not significant. Also, T3SS1 may contribute to the 
inflammatory response via PGE2 production and may partially 
participate in the activation of CFTR.
Opposite to T3SS1 effectors, the host inflammatory signaling 
were suppressed by T3SS2 effecter proteins. VopZ suppressed 
MAPKs and NF-κB pathway by inhibiting TAK1 activation, 
and it facilitates intestinal colonization (32). Also, VopA inhibit 
MAPKs signaling pathway by acetylation of catalytic loop (33). 
Those effectors may affect COX-2 production in infection site. 
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Fig S2.
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Fig S3.　Production of PGE2, cAMP and GABA in mouse intestinal mucosa infected with V. parahaemolyticus analyzed by 
CE-TOFMS.  The amount of CFTR activator in V. parahaemolyticus-infected mouse intestinal mucosa were isolated from 
loop assay tissue and estimated by CE-TOFMS. The error bar indicates standard deviation. Data differing significantly 
from PBS are marked by * (Student’s t-test) (n = 8). *p < 0.05.
Fig 2.　COX contribution to V. parahaemolyticus-induced fluid 
accumulation. Bacterial suspensions with COX inhibitors 
(indomethacin or NS398) were injected to mouse intestinal loops. 
After infection for 4 h, fluid accumulation was calculated (n = 6 
to 8). Box plot showing fluid accumulation, as determined by the 
mouse intestinal loop assay with COX inhibitors. Upper horizontal 
line of box, 75th percentile ; lower horizontal line of box, 25th 
percentile ; horizontal bar within box, median ; upper horizontal bar 
outside of box, maximum value ; lower horizontal bar outside of box, 
minimum value. Different letters of the alphabet indicate statistical 
difference (p < 0.01) from each other as determined by ANOVA with 
Tukey Kramer’s test.
Fig S2.　Measure of metabolome in mouse intestinal mucosa infected with V. parahaemolyticus analyzed by CE-TOFMS. 
The amount of metabolites in V. parahaemolyticus-infected mouse intestinal mucosa were isolated from loop assay tissue 
and analyzed by CE-TOFMS. Those data were categorized in cationic metabolites (A) and anionic metabolites (B), 
respectively. The error bar indicates standard deviation. Data differing significantly from PBS are marked by * (Student’s 
t-test) (n = 8). *p < 0.05. Relative quantitative comparisons were described (C).
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Fig 3.　Confirmation of V. parahaemolyticus-induced neutrophil infiltration in mouse ileal tissue. (A, B) The intestinal 
tissues were infected with V. parahaemolyticus for 4 h or treated with PBS as a control samples under the loop model, 
and tissue were stained with HE and observed under a microscope. Scale bar = 50 μm. Arrows indicates neutrophil 
infiltration. The error bar indicates standard deviation. (C) Expression levels of mRNA in inflammatory cytokine were 
estimated by Real-time RT-PCR of mouse intestinal loops infected with V. parahaemolyticus for 4 h. Non-infected control 
(PBS) set as 1. The error bar indicates standard deviation. *p < 0.05 (PBS vs. VP ; Student’s t-test). (D) MPO protein levels 
were estimated by western blot analysis of mouse intestinal loops infected with V. parahaemolyticus for 4 h. MPO was 
detected using specific Abs. β-actin was detected as a loading control. Relative band intensities were calculated. The error 
bar indicates standard deviation. *p < 0.01 (PBS vs. VP ; Student’s t-test).
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Fig 4.　COX-2 expression levels in V. parahaemolyticus-infected mouse intestine. (A) COX-2 and COX-1 protein levels in 
mouse tissues were quantified by western blot analysis by using specific Abs. Glyceraldehyde 3-phosphate dehydrogenase 
was detected as a loading control. (B) Relative band intensities of COX-2 and COX-1. (C) COX-2 mRNA expression levels 
in mouse intestines were analyzed by real-time RT-PCR. The error bar indicates standard deviation. Data differing 
significantly from PBS are marked by * (Student’s t-test). *p < 0.01
Fig 5.　Distribution of COX-2 and MPO in the mouse intestine. Distribution of COX-2 and MPO were detected by 
immunofluorescence analysis with specific Abs. A, F : Nuclear localization. B, G : Distribution of COX-2. C, H : distribution 
of MPO. D, I : Colocalization of COX-2 and MPO. E, J : Differential interference contrast image. A-E : Non-infected tissue, 
F-J : Tissue infected with V. parahaemolyticus for 4 h. Scale bar = 50 μm.
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Fig S4.　COX-2 expression levels in V. parahaemolyticus-in-
fected RAW264.7 and peritoneal macrophage. COX-2 protein 
levels in V. parahaemolyticus-mutant strains or killed V. parahae-
molyticus (95℃ 5 min heated, 100 μg / mL gentamicin treated, 
and 5 min exposed 280 nm: UVC) treated cells were estimated 
by western blot analysis in RAW264.7 (A) or mouse peritoneal 
macrophage (B) for 4 h treatment. Each cell lysates were 
normalized by protein contents. COX-2 was detected using 
specific Abs. β-actin was detected as a loading control.
Fig S5.　Infiltration of neutrophils in mouse intestine by Heat-killed-bacteria in vivo. (A) Bacterial suspension (VP ; wild type 
or HK ; heat-killed V. parahaemolyticus) or PBS was injected to the intestinal loops of mouse. After infection for 6 h, the loops were 
removed and fluid accumulation was calculated (n = 8 to 10). Box plot showing fluid accumulation, as determined with a mouse 
intestinal loop assay. Upper horizontal line of box, 75th percentile ; lower horizontal line of box, 25th percentile ; horizontal bar 
within box, median ; upper horizontal bar outside of box, maximum value ; lower horizontal bar outside of box, minimum value. 
Different letters of the alphabet indicate statistical difference (p < 0.05) from each other as determined by ANOVA with Tukey 
Kramer’s test. (B) The mice were infected with V. parahaemolyticus, treated with Heat-killed-bacteria or PBS (control samples) for 
6 h under the loop model, which tissues were stained with HE and observed under a microscope. Scale bar = 200 μm. (C) MPO 
protein levels were estimated by western blot analysis in each mouse. MPO was detected using specific Abs. β-actin was detected 
as a loading control. Relative band intensities were calculated. The error bar indicates standard deviation. Different letters of the 
alphabet indicate statistical difference (p < 0.05) from each other as determined by ANOVA with Tukey Kramer’s test.
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However, still effectors secretion rate or balance between T3SS1 
and T3SS2 are not clear in infection site. On the other hand, 
the T3SS2 effecter protein VopV was identified as the main 
factor of F-actin-mediated diarrhea in rabbits, as confirmed 
with the loop test (14). Also, other T3SS2 effector proteins (i.e., 
VopL and VopC) modulate actin stress fibers (34-37). Still, a 
relationship between CFTR channel and actin fiber formation 
has been reported. CFTR activity is modulated by actin filament 
organization via a functional interaction that can be achieved 
independently via the cAMP-PKA-mediated regulatory pathway 
(38). It is also possible that V. parahaemolyticus-induced inflam-
mation may promote T3SS2-induced modulation of actin fila-
ments and facilitate CFTR-mediated V. parahaemolyticus-induced 
diarrhea.
There are many factors associated with the formation and 
function of ion channels in secretory diarrhea in the mouse loop 
model. However, the focus of the present study was limited to the 
effect of CFTR in V. parahaemolyticus-induced diarrhea. Unfor-
tunately, it was not possible to completely reveal the underlying 
mechanisms. In our next study, we plan to investigate other di-
arrhea-associated channel factor, such as the calcium-activated 
chloride channels, which are activated in secretory diarrhea in 
Vibrio cholerae O1 El Tor variant induced diarrhea in mice (39), 
or GABA, which is a primary neurotransmitter in the central 
nervous system and also regulates the function of the gastroin-
testinal tract. These factors also participate in intestinal fluid 
secretion of the mouse (40). Hence, future investigations are 
warranted to further elucidate the mechanisms underlying fluid 
accumulation in response to V. parahaemolyticus infection.
CONCLUSION
This study reveals an important relationship between V. par-
ahaemolyticus-induced diarrhea and inflammation in a mouse 
model. Our data suggested that V. parahaemolyticus-inducing 
infiltration and activation of neutrophils were closely associated 
with CFTR mediated fluid secretion. Our finding may serve to 
elucidate the mechanism of V. parahaemolyticus-induced diarrhea 
in detail. 
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